Total Visits

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study74

Select a period of time:

Views

Views
February 20250
March 202518
April 202512
May 20255
June 20251
July 202513
August 20254
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
Hong Kong11
United States9
Brazil4
Germany2
Finland2
Austria2
Colombia1
Spain1
Mexico1
 

Top cities views

Views
Hong Kong11
Turku2
Vienna2
Nuremberg2
Amsterdam1
Ankara1
Brooklyn1
Cabo Frio1
Cabo San Lucas1
Council Bluffs1